One-on-One with Jim Knighton of AvidBiotics

AvidBiotics Corp. started work in human therapeutics several years ago, but it’s really taken a liking to food.

Just in time for the holidays, researchers at Harvard Medical School’s Brigham and Women’s Hospital and AvidBiotics said Monday that the South San Francisco-based company’s Avidocin proteins could prevent and treat E. coli-related diarrhea and intestinal inflammation in animals.

If the Thanksgiving table conversation turns staid, you can find the results of the study in the December issue of the journal Antimicrobial Agents and Chemotherapy.

I spoke with Jim Knighton, co-founder and president of the “nine-people-and-a-dog” company, about the company’s food safety program, a key partnership and the new study.

Read or purchase full article from: San Francisco Business Times